We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-3.14%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$52.8B
AUM Growth
-$1.34B
Cap. Flow
+$1.39B
Cap. Flow %
2.62%
Top 10 Hldgs %
12%
Holding
4,607
New
780
Increased
956
Reduced
789
Closed
1,336

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$532M
2
WFC icon
Wells Fargo
WFC
+$480M
3
V icon
Visa
V
+$435M
4
VZ icon
Verizon
VZ
+$320M
5
AVGO icon
Broadcom
AVGO
+$273M

Sector Composition

Rank Sector Weight
1 Financials 18.66%
2 Technology 16.35%
3 Healthcare 16.13%
4 Consumer Discretionary 11.2%
5 Industrials 7.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GTPA
1726
DELISTED
Gores Technology Partners, Inc. Class A Common Stock
GTPA
$3.18M 0.01%
324,298
AMX icon
1727
America Movil
AMX
$77.2B
$3.17M 0.01%
+150,096
New +$2.9M
ISOS.WS
1728
CALL
DELISTED
Isos Acquisition Corporation Warrants, each whole warrant exercisable for one Class A ordinary share
ISOS.WS
$3.17M 0.01%
297,965
-121,798
-29% -$1.3M
GRNAW
1729
CALL
DELISTED
GreenLight Biosciences Holdings, PBC Warrant
GRNAW
$3.17M 0.01%
329,288
+100,000
+44% +$73.2K
OWL.WS
1730
CALL
DELISTED
Blue Owl Capital Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A C
OWL.WS
$3.17M 0.01%
249,996
OPRT icon
1731
Oportun Financial
OPRT
$264M
$3.17M 0.01%
220,507
+33,389
+18% +$557K
RNST icon
1732
Renasant Corp
RNST
$4.05B
$3.16M 0.01%
+94,434
New +$3.46M
ARTAW
1733
CALL
DELISTED
Artisan Acquisition Corp. Warrants
ARTAW
$3.16M 0.01%
320,000
HMCOW
1734
CALL
DELISTED
HumanCo Acquisition Corp. Warrant
HMCOW
$3.15M 0.01%
321,690
+21,697
+7% +$11.4K
RRAC.WS
1735
CALL
DELISTED
Rigel Resource Acquisition Corp Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
RRAC.WS
$3.13M 0.01%
+315,254
New +$140K
CDXS icon
1736
Codexis
CDXS
$161M
$3.13M 0.01%
151,807
-562,016
-79% -$11.6M
DCFCW
1737
CALL
DELISTED
Tritium DCFC Limited Warrant
DCFCW
$3.13M 0.01%
+311,214
New +$560K
ICUCW
1738
CALL
SeaStar Medical Holding Corp Warrant
ICUCW
$3.11M 0.01%
307,659
AVLR
1739
DELISTED
Avalara, Inc.
AVLR
$3.11M 0.01%
31,294
+22,534
+257% +$2.28M
INTE
1740
DELISTED
Integral Acquisition Corporation 1 Class A Common Stock
INTE
$3.11M 0.01%
314,240
+3,296
+1% +$32.5K
NBIS
1741
Nebius Group N.V.
NBIS
$43.1B
$3.1M 0.01%
547,676
+323,386
+144% +$15.4M
SUZ icon
1742
Suzano
SUZ
$10.4B
$3.08M 0.01%
265,434
+254,245
+2,272% +$2.87M
AUROW
1743
CALL
Aurora Innovation Warrant
AUROW
$386M
$3.07M 0.01%
550,000
-5,000
-0.9% -$6.59K
LFACW
1744
CALL
DELISTED
LF Capital Acquisition Corp. II Warrants
LFACW
$3.07M 0.01%
+307,457
New +$91.4K
LOCC.WS
1745
CALL
DELISTED
Live Oak Crestview Climate Acquisition Corp. Warrants, exercisable for one share of Class A common stock at an exercise price of $11.50 per share
LOCC.WS
$3.07M 0.01%
316,662
INSG icon
1746
Inseego
INSG
$111M
$3.06M 0.01%
75,602
+67,715
+859% +$3.1M
XBPEW
1747
CALL
XBP Europe Holdings Warrant
XBPEW
$3.05M 0.01%
302,521
-811
-0.3% -$398
EDNCW
1748
CALL
DELISTED
Endurance Acquisition Corp. Warrant
EDNCW
$3.04M 0.01%
309,109
QQQ icon
1749
Invesco QQQ Trust
QQQ
$445B
$3.04M 0.01%
+8,385
New +$2.98M
FATP
1750
DELISTED
Fat Projects Acquisition Corp Class A Ordinary Share
FATP
$3.03M 0.01%
307,370

Similar funds

Marshall Wace's Q1 2022 Portfolio in Review

As of Q1 2022, Marshall Wace held 4,607 positions worth $52.8B, down 2.5% from $54.2B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Marshall Wace's Q1 2022 filing shows 780 new, 956 increased, 789 reduced and 1,336 closed positions. Its largest new stake was Agilent Technologies: 1,082,487 shares worth $143M. The largest sale was Microsoft, an estimated $547M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • Marshall Wace's largest Q1 2022 buy was Agilent Technologies: 1,082,487 shares worth $143M.
  • Marshall Wace added most to Merck in Q1 2022, an estimated $532M increase.
  • Marshall Wace's biggest Q1 2022 reduction was Microsoft, cutting an estimated $547M.
  • Marshall Wace fully exited Elevance Health in Q1 2022, selling an estimated $226M.
  • Marshall Wace's ten largest holdings make up 12% of its $52.8B portfolio in Q1 2022.
  • Marshall Wace opened 780 new positions and closed 1,336 in Q1 2022.
  • Marshall Wace's portfolio value fell 2.5% quarter-over-quarter to $52.8B.

Based on Marshall Wace's 13F filing for Q1 2022, filed 16 May 2022.